<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

CU Cancer Center News and Stories


Research    Awards    lymphoma

Rosemary Rochford, PhD, Receives Henle Award for Decades of Research on Epstein-Barr Virus-Related Cancer

University of Colorado Cancer Center member Rosemary Rochford, PhD, has spent the past 34 years researching the Epstein-Barr virus (EBV) a virus that causes several types of cancer, including Burkitt lymphoma, nasopharyngeal carcinoma, gastric carcinoma, Hodgkin’s disease, and non-Hodgkin’s lymphoma. 

Author Greg Glasgow | Publish Date April 25, 2024
Full Story

Research    Funding    Awards    Cell and Gene Therapy

Project to Rev Up Cancer-Fighting Cells Wins Anschutz Acceleration Initiative Grant

A project to develop a way to boost the effectiveness of cellular cancer therapies, led by the University of Colorado Cancer Center’s Associate Director of Cancer Research Training and Education Coordination, Eduardo Davila, PhD, is one of nine research endeavors by CU School of Medicine faculty members to be awarded major funding from the Anschutz Acceleration Initiative.

Author Mark Harden | Publish Date February 02, 2024
Full Story

Research    DNA    Awards

Karolin Luger, PhD, Honored By World Laureates Association

University of Colorado Cancer Center member Karolin Luger, PhD, a distinguished professor of biochemistry at CU Boulder, has been awarded the 2023 World Laureates Association (WLA) Prize in Life Science or Medicine.

Author Greg Glasgow | Publish Date October 13, 2023
Full Story

Research    Breast Cancer    Awards

Clinician Scientist Development Grant From the American Cancer Society Will Help Sarah Tevis, MD, Advance Her Research on Breast Cancer Outcomes 

For the past four years, University of Colorado Cancer Center member Sarah Tevis, MD, has focused her research on the psychosocial outcomes of breast surgery for women with breast cancer — specifically comparing patient-reported outcomes three and six months after receiving a lumpectomy (surgery in which just the tumor and some of the surrounding cells are removed) and a mastectomy (surgery to remove the entire breast). 

Author Greg Glasgow | Publish Date June 14, 2023
Full Story

Research    Blood Cancer    Awards

Overcoming Drug Resistance in Multiple Myeloma 

The good news for people with multiple myeloma is that treatments exist that almost always put the cancer into deep remission soon after it’s diagnosed. The bad news for people with the blood cancer, though, is that even though that remission can last several years, almost all patients eventually relapse — and the disease that returns becomes increasingly difficult to treat. 

Author Greg Glasgow | Publish Date June 12, 2023
Full Story

Research    Surgical Oncology    Awards

CU Cancer Center Member Named to National Cancer Institute Early-Stage Surgeon Scientist Program 

For her innovative research on how cannabinoids affect the tumor immune microenvironment in melanomaUniversity of Colorado Cancer Center member Camille Stewart, MD, has been named to the 2023 cohort of the National Cancer Institute’s Early-Stage Surgeon Scientist Program (ESSP). The National Cancer Institute coordinates the United States National Cancer Program and is part of the National Institutes of Health (NIH). 

Author Greg Glasgow | Publish Date March 24, 2023
Full Story

Research    Awards

Sojourns Scholar Award Will Support Hospice Research in Communities of Color

Channing E. Tate, PhD, MPH, University of Colorado Cancer Center Rising Star, has seen through her personal and professional experiences how aging populations and communities of color often fall through the cracks of health care, especially at the end of life.

Author Rachel Sauer | Publish Date March 07, 2023
Full Story

Thyroid Cancer    Awards

Bryan Haugen, MD, Receives Outstanding Scholarly Physician Award from the Endocrine Society

University of Colorado Cancer Center member Bryan Haugen, MD, always knew he was a science person. His question was if he wanted to be a MD or a PhD. After completing his bachelor’s degree at Saint Olaf College in Minnesota, he did a few years of research at the Mayo Clinic before starting medical school there.

Author Jessica Cordova | Publish Date October 27, 2022
Full Story

CU Cancer Center In the News

News Medical

Study shows effectiveness of treating pancreatic cancer patients with chemotherapy before surgery

news outletNews Medical
Publish DateJune 19, 2024

A new study led by University of Colorado Cancer Center member Marco Del Chiaro, MD, PhD, reveals that nearly 5% of pancreatic adenocarcinoma patients achieved a pathological complete response (pCR) after pre-surgical chemotherapy or chemoradiotherapy. This significant finding indicates that patients with pCR have a 63% five-year survival rate, compared to 30% for those without pCR, suggesting the potential for tailored treatments to improve outcomes.

Full Story
Cancer Network

Liso-cel May Show Benefit in Earlier Therapy Lines for Lymphoma Subgroups

news outletCancer Network
Publish DateJune 14, 2024

In a conversation at the 2024 European Hematology Association Congress, CU Cancer Center member Manali Kamdar, MD, discussed potential future research on lisocabtagene maraleucel (liso-cel; Breyanzi) for mantle cell lymphoma (MCL) and other lymphoma subgroups. She highlighted findings from the phase 1 TRANSCEND NHL 001 trial, noting improved efficacy and safety in patients with fewer prior therapies and non-refractory disease, suggesting liso-cel's utility in earlier treatment lines and specific lymphoma subgroups.

Full Story
Cancer Health

2024 Cancer Health 25: People Who Power Clinical Trials

news outletCancer Health
Publish DateJune 11, 2024

This year's Cancer Health 25 highlights the transformative power and promise of clinical trials. University of Colorado Cancer Center member Jessica McDermott, MD, MSCS, is leading clinical trials at both the CU Cancer Center and the Rocky Mountain Regional Veterans Affairs Medical Center. Additionally, she serves as the CU Cancer Center's deputy associate director for diversity and inclusion in clinical research.

Full Story
Cancer Network

Learning to “Aim High” Within Male-Dominated Fields in Public Health

news outletCancer Network
Publish DateJune 10, 2024

Cathy Bradley, PhD, deputy director of the University of Colorado Cancer Center and dean of the Colorado School of Public Health, is a trailblazer in health economics. At a Breaking Barriers: Women in Oncology discussion, she shared insights on overcoming challenges as a woman in a male-dominated field and discussed her research on the impact of employment on cancer patients' health insurance decisions.

Full Story